SCHEMBL29501680

SCHEMBL29501680

COc1ccccc1P(c1ccccc1)c1cc(C(C)(C)C)cc2c1Oc1c(P(c3ccccc3)c3ccccc3OC)cc(C(C)(C)C)cc1C2(C)C

nearest known ligand 0.50

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
DRD1 P21728 2/20 0.50
STK10 O94804 1/20 0.30
SLK Q9H2G2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21111904 1.00 DRD1 (0.50) DRD1STK10SLK
SCHEMBL21111744 0.88 DRD1 (0.47) DRD1
SCHEMBL29501683 0.88 DRD1 (0.47) DRD1
SCHEMBL21111875 0.88 DRD1 (0.47) DRD1
SCHEMBL708320 0.86 DRD1 (0.61) DRD1
SCHEMBL21111795 0.85 DRD1 (0.51) DRD1
SCHEMBL29501639 0.85 DRD1 (0.51) DRD1
SCHEMBL21111755 0.84 DRD1 (0.53) DRD1
SCHEMBL21111890 0.84 DRD1 (0.50) DRD1
SCHEMBL31758930 0.83 DRD1 (0.74) DRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250154090-A1 PROCESS FOR PREPARING GAMMA,DELTA-UNSATURATED ALDEHYDES DERIVATIVES FIRMENICH SA (CH) 2025-05-15 US disclosed
EP-4486717-A1 PROCESS FOR PREPARING GAMMA,DELTA-UNSATURATED ALDEHYDES DERIVATIVES Firmenich SA (CH) 2025-01-08 EP disclosed
EP-4486732-A1 PROCESS FOR PREPARING UNSATURATED ALDEHYDES Firmenich SA (CH) 2025-01-08 EP disclosed
CN-118829633-A Process for preparing unsaturated aldehydes 弗门尼舍有限公司 2024-10-22 CN disclosed
CN-118804908-A Process for preparing gamma, delta-unsaturated aldehyde derivatives 弗门尼舍有限公司 2024-10-18 CN disclosed
WO-2023166005-A1 PROCESS FOR PREPARING UNSATURATED ALDEHYDES FIRMENICH SA (CH) 2023-09-07 WO disclosed
WO-2023166004-A1 PROCESS FOR PREPARING GAMMA,DELTA-UNSATURATED ALDEHYDES DERIVATIVES FIRMENICH SA (CH) 2023-09-07 WO disclosed
CN-116018334-A Process for preparing 3- (cyclohex-1-en-1-yl) propanal derivatives 弗门尼舍有限公司 2023-04-25 CN disclosed
EP-4153552-A2 PROCESS AND INTERMEDIATES FOR PREPARING 3-(CYCLOHEX-1-EN-1-YL) PROPANAL DERIVATIVES Firmenich SA (CH) 2023-03-29 EP disclosed
WO-2022049036-A2 PROCESS FOR PREPARING 3-(CYCLOHEX-1-EN-1-YL)PROPANAL DERIVATIVES FIRMENICH SA (CH) 2022-03-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250154090-A1 PROCESS FOR PREPARING GAMMA,DELTA-UNSATURATED ALDEHYDES DERIVATIVES DEGS1, EBP, FASN DRD1 1505/4885STK10 3678/4885SLK 3283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.